Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/38341
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.advisor | BITO, Virginie | |
dc.contributor.author | Jager, Manon Marie | |
dc.date.accessioned | 2022-09-26T08:19:41Z | - |
dc.date.available | 2022-09-26T08:19:41Z | - |
dc.date.issued | 2022 | |
dc.identifier.uri | http://hdl.handle.net/1942/38341 | - |
dc.format.mimetype | Application/pdf | |
dc.language | en | |
dc.publisher | tUL | |
dc.title | Using pyridoxamine to limit cardiovascular toxicity during doxorubicin chemotherapy | |
dc.type | Theses and Dissertations | |
local.bibliographicCitation.jcat | T2 | |
dc.description.notes | Master of Biomedical Sciences-Molecular Mechanisms in Health and Disease | |
local.type.specified | Master thesis | |
item.fullcitation | Jager, Manon Marie (2022) Using pyridoxamine to limit cardiovascular toxicity during doxorubicin chemotherapy. | - |
item.accessRights | Open Access | - |
item.fulltext | With Fulltext | - |
item.contributor | Jager, Manon Marie | - |
Appears in Collections: | Master theses |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
51293e0d-82f6-468c-9860-1e22f12597f7.pdf | 1.62 MB | Adobe PDF | View/Open |
Page view(s)
64
checked on Sep 10, 2023
Download(s)
84
checked on Sep 10, 2023
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.